Increased KL-6 levels in moderate to severe COVID-19 infection.

Maureen CambierMonique HenketAnne Noelle FrixStéphanie GofflotMarie ThysSara TomasettiAnna Julie PeiredIngrid StrumanAnne-Françoise RousseauBenoît MissetGilles DarcisMichel MoutschenRenaud LouisMakon-Sébastien NjockEtienne CavalierJulien Guiot

Published in: PloS one (2022)

KL-6 expression was correlated with several disease severity indicators. However, the association between mortality and long-term follow-up outcomes needs further investigation. More extensive trials are required to prove that KL-6 could be a marker of disease severity in COVID-19 infection.

Keyphrases

poor prognosis
cardiovascular events
high intensity
early onset
risk factors
binding protein
type diabetes
long non coding rna
skeletal muscle
insulin resistance